3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6933 | Peficitinib | ASP015K,JNJ-54781532 | Tyrosine Kinases , JAK |
Peficitinib (ASP015K) (ASP015K, JNJ-54781532) is an orally bioavailable JAK inhibitor. Phase 3. | |||
T33905 | Peficitinib hydrobromide | ||
Peficitinib hydrobromide is used in the treatment of Psoriasis and Rheumatoid Arthritis. | |||
T61365 | Peficitinib hydrochloride | ||
Peficitinib hydrochloride, also known as ASP015K, is an orally active JAK inhibitor compound. It exhibits inhibitory activity against JAK1, JAK2, JAK3, and Tyk2, with IC 50 values of 3.9, 5.0, 0.7, and 4.8 nM, respective... |